
Chondroitin Sulfate
Chondroitin sulfate is a glycosaminoglycan considered as a symptomatic slow-acting drug for osteoarthritis (SYSADOA). The SYSADOA status suggested a pain relief and increased joint mobility after a relative long regular administration, as well as a long-lasting effect after the end of the treatment. Chondroitin sulfate is composed of alternating 1,3-N-acetyl-β-d-galactosamine and 1,4-β-d-glucuronic acid units which bear 4-O- and/or 6-O-sulfations at the N-acetylgalactosamine units disposed of in specific patterns. Depending on the predominating disaccharide unit, it will present different biological activities. Chondroitin sulfate is sold as an OTC dietary supplement in North America and it is a prescription drug under the EMA in Europe. — DrugBank
- IUPAC 명칭
- (2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
- 분자식
- C13H21NO15S
- 분자량
- 463.37 g/mol
- 정확한 질량
- 463.06319014 Da
- XLogP3
- -4.8
- 위상 극성 표면적
- 267.0 Ų
- 수소 결합 공여체
- 8
- 수소 결합 수용체
- 15
- 공유결합 단위
- 1
- 정의된 입체중심
- 10
다른 이름
보고된 명칭 16개 더 보기
외부 데이터베이스 식별자
- ChEMBL:CHEMBL5266347
- EPA DTXSID:DTXSID601017238
- PubMed:5601
체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.